天齊鋰業(002466.SZ):正在建設的安居工廠年產2萬噸電池級碳酸鋰項目預計將於今年下半年竣工並進入調試階段
格隆匯6月28日丨有投資者向天齊鋰業(002466.SZ)提問,“公司是否考慮披露二季度預吿,還有公司二季度相對於一季度新增了多少產能,以及現在公司在鋰鹽價格不高的情況下,盈利能力影響怎麼樣?”
天齊鋰業回覆稱,目前公司鋰化合物及衍生品建成產能仍然為6.88萬噸/年,公司正在建設的安居工廠年產2萬噸電池級碳酸鋰項目預計將於今年下半年竣工並進入調試階段。公司將嚴格按照《深圳證券交易所股票上市規則(2022年修訂)》等法律法規和規範性文件的相關規定進行信息披露,公司今年半年度業績情況請您以公司後續披露的相關公吿為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.